Zobrazeno 1 - 10
of 85
pro vyhledávání: '"William G Breen"'
Autor:
Mason J Webb, William G Breen, Nadia N Laack, Konstantinos Leventakos, Jian L Campian, Ugur Sener
Publikováno v:
CNS Oncology, Vol 12, Iss 3 (2023)
Leptomeningeal disease (LMD) remains a challenging condition with a dismal prognosis. In this case study, we report partial response of LMD in a patient with metastatic large cell neuroendocrine carcinoma following treatment with proton craniospinal
Externí odkaz:
https://doaj.org/article/d3b7047a102c45deb04e6372c3d0e4c3
Autor:
Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley J Stish, Allison Rosenthal, Javier Munoz, Yi Lin, Radhika Bansal, Matthew A Hathcock, Patrick B Johnston, Stephen M Ansell, Jonas Paludo, Arushi Khurana, Jose C Villasboas, Yucai Wang, Madiha Iqbal, Muhamad Alhaj Moustafa, Hemant S Murthy, Mohamed A. Kharfan-Dabaja, Jennifer L Peterson, Bradford S Hoppe
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
Majority of non-Hodgkin lymphoma (NHL) patients who achieve partial response (PR) or stable disease (SD) to CAR T-cell therapy (CAR T) on day +30 progress and only 30% achieve spontaneous complete response (CR). This study is the first to evaluate th
Externí odkaz:
https://doaj.org/article/009ce022ca6d41d08e025c301d3cb70a
Autor:
Kelsey M. Frechette, Scott C. Lester, Kekoa Taparra, William G. Breen, James A. Martenson, Bradford S. Hoppe, Jennifer L. Peterson, William G. Rule, Scott L. Stafford, Bradley J. Stish, Thomas M. Habermann, Jason R. Young, William S. Harmsen, Nadia N. Laack
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 8, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/85ee220edf2e4ce6be016613687e4f51
Autor:
William G. Breen, Matthew A. Hathcock, Jason R. Young, Roman O. Kowalchuk, Radhika Bansal, Arushi Khurana, N. Nora Bennani, Jonas Paludo, Jose C. Villasboas Bisneto, Yucai Wang, Stephen M. Ansell, Jennifer L. Peterson, Patrick B. Johnston, Scott C. Lester, Yi Lin
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-4 (2022)
Abstract Background F-18 fluorodeoxyglucose positron emission tomography computed tomography (PET/CT) is used to assess response of non-Hodgkin lymphoma (NHL) to chimeric antigen receptor T cell (CAR-T) therapy. We sought to describe metabolic and vo
Externí odkaz:
https://doaj.org/article/9d595cf3f02d4656883f7dc6f35707bd
Autor:
Croix C. Fossum, MD, William G. Breen, MD, Philip Y. Sun, MD, Amber A. Retzlaff, MD, Scott H. Okuno, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 2, Pp 143-149 (2020)
Objective: To assess familiarity with sarcoma guidelines among primary care practitioners (PCPs) in Minnesota. Participants and Methods: Surveys were distributed at 2 educational conferences held in Minnesota on April 16-17, 2015, and October 24, 201
Externí odkaz:
https://doaj.org/article/92731e355cba413d9c7921e2a0cc14d5
Autor:
Matthew R. Buras, William G. Breen, Nadia N. Laack, Tamara Vern- Gross, Isabella Zaniletti, Todd Leavitt, Michael A. Golafshar, Molly M. Voss, Anita Mahajan, Sameer R. Keole, Safia K. Ahmed, Annissa Ulbrich, Thomas B. Daniels, Todd A. DeWees
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:472-477
Patient-reported outcomes provide quality of life (QOL) data during and after radiation. When pediatric patients are unable to complete patient-reported outcomes, it is unknown whether caregiver responses are an accurate surrogate. We assessed whethe
Autor:
William G. Breen, Yolanda I. Garces, Kenneth R. Olivier, Sean S. Park, Kenneth W. Merrell, Francis C. Nichols, Tobias D. Peikert, Julian R. Molina, Aaron S. Mansfield, Anja C. Roden, Shanda H. Blackmon, Dennis A. Wigle
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: The optimal treatment sequence for localized malignant pleural mesothelioma (MPM) is controversial. We aimed to assess outcomes and toxicities of treating localized MPM with neoadjuvant radiation therapy (RT) followed by extrapleural pneu
Externí odkaz:
https://doaj.org/article/b5222ff703734268b10964c8ccd16177
Autor:
Roman O. Kowalchuk, Hayeon Kim, William S. Harmsen, Elizabeth B. Jeans, Lindsay K. Morris, Trey C. Mullikin, Robert C. Miller, William W. Wong, Carlos E. Vargas, Daniel M. Trifiletti, Ryan M. Phillips, C. R. Choo, Brian J. Davis, Sushil Beriwal, Rahul D. Tendulkar, Bradley J. Stish, William G. Breen, Mark R. Waddle
Publikováno v:
Cancer. 128:3815-3823
Patients with high-risk prostate cancer (HRPC) have multiple accepted treatment options. Because there is no overall survival benefit of one option over another, appropriate treatment must consider patient life expectancy, quality of life, and cost.T
Autor:
William G. Breen, BA, Kenneth W. Merrell, MD, Aaron S. Mansfield, MD, Dennis A. Wigle, MD PhD, Yolanda I. Garces, MD, Sean S. Park, MD PhD, Kenneth R. Olivier, MD, Christopher L. Hallemeier, MD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 1, Pp 12-18 (2017)
Purpose: For patients with stage III (N2) non–small cell lung cancer (NSCLC) treated with surgical resection, postoperative chemotherapy improves overall survival (OS), but the role of postoperative radiation therapy (PORT) is controversial. The pu
Externí odkaz:
https://doaj.org/article/e691d83d7f4344baa7ceceee363e647a
Autor:
William G. Breen, Ryan S. Youland, Sharmila Giri, Sawyer B. Jacobson, Deanna H. Pafundi, Paul D. Brown, Christopher H. Hunt, Anita Mahajan, Michael W. Ruff, Sani H. Kizilbash, Joon H. Uhm, David M. Routman, Jamecca E. Jones, Debra H. Brinkmann, Nadia N. Laack
Publikováno v:
Journal of Neuro-Oncology. 158:323-330